KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Free Cash Flow (2016 - 2025)

Teladoc Health's Free Cash Flow history spans 12 years, with the latest figure at $85.1 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 474.96% year-over-year to $85.1 million; the TTM value through Dec 2025 reached $285.5 million, up 58.22%, while the annual FY2025 figure was $285.5 million, 58.22% up from the prior year.
  • Free Cash Flow for Q4 2025 was $85.1 million at Teladoc Health, down from $150.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $165.7 million in Q3 2024 and bottomed at -$35.7 million in Q1 2022.
  • The 5-year median for Free Cash Flow is $30.0 million (2021), against an average of $42.1 million.
  • The largest annual shift saw Free Cash Flow crashed 176.59% in 2021 before it soared 190378.16% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $33.4 million in 2021, then tumbled by 46.58% to $17.9 million in 2022, then soared by 432.01% to $95.0 million in 2023, then tumbled by 123.9% to -$22.7 million in 2024, then skyrocketed by 474.96% to $85.1 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Free Cash Flow are $85.1 million (Q4 2025), $150.8 million (Q3 2025), and $62.5 million (Q2 2025).